Company Profile

  1. You are here:    Home
  2. Search Databases
  3. Search Company Registry
  4. Company Profile

FYR Diagnostics LLC
Profile last edited on: 3/14/2023      CAGE: 7TME7      UEI: ZNBDGKJL1BD6

Business Identifier: Diagnostic tools for diseases with large unmet clinical needs
Year Founded
2017
First Award
2019
Latest Award
2021
Program Status
Active
Popularity Index

Edit Company Profile

Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.
  Explanation Edit

Location Information

1121 East Broadway Street MonTEC Suite 155
Missoula, MT 59802
   (214) 748-3647
   N/A
   www.fyrdiagnostics.com
Location: Single
Congr. District: 01
County: Missoula

Public Profile

FYR Diagnostics is a early stage biotechnology company developing next-generation detection technologies for rapid, accurate diagnostics. Strong focus on non-coding RNAs, such as miRNA. The firm's technology(ies) can be used to for early stage diagnosis of disease as well treatment efficacy. Areas of potential application relevance include Blood-based diagnostics; Novel DNA and RNA amplification tools and Agriculture disease detection

Extent of SBIR involvement

User Avatar
Phase I Awards
3
Phase II Awards
1
Conversion Rate
33.33%
Phase I Dollars
$940,944
Phase II Dollars
$284,262
Total Awarded
$1,225,206

Synopsis: Awardee Business Condition

Employee Range
15-19
Revenue Range
1.5M-2M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
N/A

Awards Distribution by Agency

Most Recent SBIR Projects
Year Phase Agency Total Amount
2021 1 NIH $351,120
Project Title: PCR-based miRNA assessment of neonatal opioid withdrawal syndrome (NOWS) severity
2021 1 NSF $256,000
Project Title: The early detection of HLB Disease in citrus trees utilizing a novel isothermal PCR technology to identify host small RNAs
2020 2 NIH $618,086
Project Title: Project isoPTE: Isothermic Post-Traumatic Epilepsy Mirna Biomarker Detection

Key People / Management

  Sarjubhai Amratbhai Patel -- President and Co-Founder

  Chris Booth -- Director of Research and Development

  David Booth

  Braxton Norwood -- Cofounder

  Thomas Rau -- Co-Founder and Chief Scientific Officer

Company News

There are no news available.